Work

Su1729 TIME TO FIRST REMISSION AND PREVALENCE OF SUSTAINED REMISSION IN INFLAMMATORY BOWEL DISEASE: COMPARISON BETWEEN INFLIXIMAB BIOSIMILAR AND ORIGINATOR

Year: 2023

Type: conference-abstract

Source: Gastroenterology

DOI: 10.1016/s0016-5085(23)02527-1

Authors: Marina G. Birck, Luck Lukusa, Waqqas Afif, Peter L. Lakatos, Talat Bessissow, Harminder Singh, Banke Oketola, Neeraj Narula, Yvette Leung, Sasha Bernatsky

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4383466145

Cites:

Cited by:

Related to: 10